As of September 2024, Getein Biotech has a market cap of $531.37M. This makes Getein Biotech the world's 11000th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $620.41M | -20.82% |
2023 | $783.52M | -12.00% |
2022 | $890.37M | -12.76% |
2021 | $1.02B | -17.95% |
2020 | $1.24B | 48.50% |
2019 | $837.67M | 21.45% |
2018 | $689.71M | -37.98% |
2017 | $1.11B | - |